NCT00404898 NYU/Bellevue WTC Health Impacts Research Registry
| NCT ID | NCT00404898 |
| Status | Recruiting |
| Phase | — |
| Sponsor | NYU Langone Health |
| Condition | Exposure to World Trade Center Dust |
| Study Type | OBSERVATIONAL |
| Enrollment | 40,000 participants |
| Start Date | 2007-12 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40,000 participants in total. It began in 2007-12 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The American Red Cross has funded a multidisciplinary, comprehensive evaluation and treatment program for target individuals with suspected World Trade Center (WTC)-related health problems. The populations served consist predominantly of a) local residents who were impacted by the disperion of the WTC dusts and fumes, b) individuals involved in cleaning and debris removal of local commercial spaces, and c) responders to the WTC collapse. These populations are recruited from past and ongoing programs that we have developed as well as from ongoing collaborations with community organizations that include: the Beyond Ground Zero Network, 9/11 Environmental Action committee, and the WTC Residents Coalition. In addition, there is collaboration with the Charles B. Wang Community Health Center and the centers involved in the ongoing WTC Workers and Volunteer Medical Screening and Monitoring Program. We would now like to access the data from this treatment program to create a NYU/Bellevue WTC Health Impacts Research Registry to increase knowledge about the health effects of exposure to World Trade Center dust.
Eligibility Criteria
Target populations who will participate in the Bellevue Hospital Red Cross WTC Health Impacts Program will include: * residents (children and adults) of Lower Manhattan communities at the time of the attacks, who remained or returned to their homes soon after the attacks * individuals involved in debris removal in surrounding commercial and residential buildings, * individuals involved in rescue, recovery and debris removal who have been previously screened through the World Trade Center Worker and Volunteer Medical Screening Program and are in need of continued treatment.
Contact & Investigator
Joan Reibman, MD
PRINCIPAL INVESTIGATOR
NYU Langone Health
Frequently Asked Questions
Who can join the NCT00404898 clinical trial?
This trial is open to participants of all sexes, studying Exposure to World Trade Center Dust. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00404898 currently recruiting?
Yes, NCT00404898 is actively recruiting participants. Contact the research team at joan.reibman@nyulangone.org for enrollment information.
Where is the NCT00404898 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT00404898 clinical trial?
NCT00404898 is sponsored by NYU Langone Health. The principal investigator is Joan Reibman, MD at NYU Langone Health. The trial plans to enroll 40,000 participants.